Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

EMU003941

Sigma-Aldrich

MISSION® esiRNA

targeting mouse Bik

Sign Into View Organizational & Contract Pricing

Select a Size

20 μG
$220.00
50 μG
$391.00

$220.00

Usually ships in 3 weeks (4 to 6 weeks for custom orders).
All Photos(1)

Select a Size

Change View
20 μG
$220.00
50 μG
$391.00

About This Item

UNSPSC Code:
41105324
NACRES:
NA.51

$220.00

Usually ships in 3 weeks (4 to 6 weeks for custom orders).

description

Powered by Eupheria Biotech

Quality Level

100

product line

MISSION®

form

lyophilized powder

esiRNA cDNA target sequence

AGCTTGATTCGAAGCCTCACCAACCTCAGGGAAAACATCTGGTCCTGGAGAGTCTTGACTCCTGGCGCCTGGGTGTCACCTGACCAGGACCCTGGGCAGCTGTTTCCGATGGTGCTGCTGGTCTTCTTGCTGCTGGGTGGGGCCTGGTATTTGCAGCTTCAGTGAAGTGCAGCTGGGGCAGGGCTGGTCCCTGCCCCCCAACCCCTAGAGGTGCCGGCACCCTAACTGAGGTGTTTTCTGACTGTCCCCCCCCCTTTTTATATATATATTTAACTCAGGATAGTGCTGAGATTTCATACAGGTTTTCTGGGTTTTTGTAAGGCAAATGAATTCACTGTACCTCAGGAGCATTACTGGCTAAGTGCCCCTGAGGCTTGGCTGGCCCTTCTTCTCTTGACCCCTGCTC

Ensembl | mouse accession no.

ENSMUSG00000016758

NCBI accession no.

NM_007546

shipped in

ambient

storage temp.

−20°C

Gene Information

mouse ... BIK(12124) , Bik(12124)

General description

MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.

For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.

Legal Information

MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Rubí Viedma-Rodríguez et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 36(9), 6991-7005 (2015-04-12)
Majority of women with estrogen receptor (ER)-positive breast cancers initially respond to hormone therapies such as tamoxifen (TAM; antagonist of estrogen). However, many tumors eventually become resistant to TAM. Therefore, understanding the various cellular components involved in causing resistance to

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service